-
1دورية أكاديمية
المؤلفون: Qvortrup, C, Jensen, BV, Fokstuen, T, Nielsen, SE, Keldsen, N, Glimelius, B, Bjerregaard, B, Mejer, J, Larsen, FO, Pfeiffer, P
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 21(1):87-91
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
المؤلفون: Markussen A; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Johansen JS; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark., Larsen FO; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Theile S; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Hasselby JP; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Willemoe GL; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Lorentzen T; Department of Gastroenterology, Unit of Surgical Ultrasound, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Madsen K; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Høgdall E; Department of Pathology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Poulsen TS; Department of Pathology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Wilken EE; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Geertsen P; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Behrens CP; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Roskilde, Denmark., Svane IM; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Nielsen D; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark., Chen IM; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3428-3437.
نوع المنشور: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Radiosurgery*/methods , Radiosurgery*/adverse effects , Nivolumab*/administration & dosage , Nivolumab*/therapeutic use , Biliary Tract Neoplasms*/pathology , Biliary Tract Neoplasms*/therapy , Biliary Tract Neoplasms*/drug therapy , Biliary Tract Neoplasms*/mortality , Ipilimumab*/administration & dosage , Ipilimumab*/therapeutic use, Humans ; Female ; Male ; Aged ; Middle Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aged, 80 and over ; Combined Modality Therapy